Search Results for ''

published presentations and documents on DocSlides.

Treatment Switching in the

Treatment Switching in the

by alexa-scheidler

Treatment Switching in the VenUS IV trial Method...

DCVax®-L 020221 Phase 3 Clinical Trial

DCVax®-L 020221 Phase 3 Clinical Trial

by cappi

Dendritic Cell Therapy for Brain Cancer. Where Are...

Analysis of Sustained MRD-Negativity and Progression-Free Survival of Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma Additional Data From Planned Interim Analysis of the GMMG-CONCEPT Trial

Analysis of Sustained MRD-Negativity and Progression-Free Survival of Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma Additional Data From Planned Interim Analysis of the GMMG-CONCEPT Trial

by ayaan

Progression-Free Survival of Isa-. KRd. in High-R...

Cancer Staging & Grading

Cancer Staging & Grading

by alyssa

Staff Training Meetings. Grace Ordung, Stephanie S...

Blinded Sample Size Re-estimation in a Phase III Study Investigating Progression Free Survival

Blinded Sample Size Re-estimation in a Phase III Study Investigating Progression Free Survival

by naomi

David Morgan (King’s College, London / Consultan...

A Phase III Randomized Controlled Trial of Secondary Cytoreductive Surgery followed by Platinum-Bas

A Phase III Randomized Controlled Trial of Secondary Cytoreductive Surgery followed by Platinum-Bas

by catherine

A NRG Oncology-Gynecologic Oncology Group Study. R...

Indolent Non-Hodgkin L

Indolent Non-Hodgkin L

by danika-pritchard

ymphoma. Sobia Ozair. March 8, 2017. MD Anderson ...

Blinded Sample Size Re-estimation in a Phase III Study Inve

Blinded Sample Size Re-estimation in a Phase III Study Inve

by luanne-stotts

David Morgan (King’s College, London / Consulta...

by alida-meadow

Gandara. , MD. University of California, Davis . ...

ANITA Trial Ariel pollock

ANITA Trial Ariel pollock

by jaena

Sinai journal club . 6/1/17. Case . HPI: . 69 . yo...

Phase III Clinical Trials

Phase III Clinical Trials

by morgan

Brad Rechtzigel Kohei Osterloth. "The gold standar...

ANIMAL ADAPTATIONS

ANIMAL ADAPTATIONS

by debby-jeon

SIMULATION. The Survival Island Experiment. THE S...

Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t

Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent t

by sherrill-nordquist

Yes . Deborah . Schrag. , MD, MPH. No. John L. Ma...

Kaplan-Meier Estimator

Kaplan-Meier Estimator

by giovanna-bartolotta

Bo Huang, Ching-Ray Yu and Christy Chuang-Stein. ...

No Does the New EPOC trial eliminate anti-EGFR antibodies a

No Does the New EPOC trial eliminate anti-EGFR antibodies a

by sherrill-nordquist

The New EPOC Study. Randomi. ze. Surgery. Oxalipl...

Best Practices in Nursing Management of EGFR Inhibitor Rash

Best Practices in Nursing Management of EGFR Inhibitor Rash

by olivia-moreira

Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pr...

by liane-varnes

MB ChB, MSc (Biostatistics), MD, FRCS (C-. Th. )....

Transforming treatment and improving survival for

Transforming treatment and improving survival for

by olivia-moreira

ovarian cancer patients. Laura Shawver, PhD. Foun...

Andrew H. Ko, MD University of California San Francisco

Andrew H. Ko, MD University of California San Francisco

by test

Gastrointestinal Oncology Program. Treatment of m...

Mr Eric Lim MB ChB, MSc (Biostatistics), MD, FRCS (C-

Mr Eric Lim MB ChB, MSc (Biostatistics), MD, FRCS (C-

by likets

Th. ). Consultant Thoracic Surgeon. Academic Divis...

Case Discussion

Case Discussion

by breezeibm

Hb. 6.6, platelet count . 17,000. Bone . marrow b...

by clustik

proceedings from the live CME event and may includ...

by billiontins

2018;36(8):773-9.. Nivolumab Monotherapy (Cohort 1...

A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy

A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy

by bikersjoker

patients with . advanced breast . cancer and a ger...

Diagnosis and Initial Therapy of MM

Diagnosis and Initial Therapy of MM

by tremblay

Myeloma Symposium 9/29/2018. Aric Hall, MD – Ass...

Cardiogenic Shock Where Do We Go After The SHOCK Trial

Cardiogenic Shock Where Do We Go After The SHOCK Trial

by mia

William W. O’Neill, MD. Henry Ford Health System...